Bill
Bill > SB43
KS SB43
Making and concerning appropriations for the university of Kansas medical center for fiscal years 2023, 2024 and 2025 for conducting certain clinical trials at the midwest stem cell therapy center.
summary
Introduced
01/18/2023
01/18/2023
In Committee
01/19/2023
01/19/2023
Crossed Over
Passed
Dead
04/30/2024
04/30/2024
Introduced Session
2023-2024 Regular Session
Bill Summary
AN ACT making and concerning appropriations for the fiscal years ending June 30, 2023, June 30, 2024, and June 30, 2025, for the university of Kansas medical center; relating to conducting certain clinical trials at the midwest stem cell therapy center.
AI Summary
This bill appropriates $500,000 annually from the state general fund to the University of Kansas Medical Center's Midwest Stem Cell Therapy Center (MSCTC) for the fiscal years 2023, 2024, and 2025. The funds are to be used to conduct clinical trials to treat patients with COVID-19 and other respiratory diseases using MSCTC-0010 cells developed at the center. The expenditures are to be made solely under the direction and control of the director of the MSCTC.
Committee Categories
Health and Social Services
Sponsors (0)
No sponsors listed
Other Sponsors (1)
Public Health and Welfare (S)
Last Action
Senate Died in Committee (on 04/30/2024)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | http://kslegislature.org/li/b2023_24/measures/sb43/ |
| BillText | http://kslegislature.org/li/b2023_24/measures/documents/sb43_00_0000.pdf |
Loading...